News in hepatology
Il congresso "News in Hepatology" si svolge a Napoli il 9-10 ottobre 2026 presso l'Hotel Palazzo Alabardieri e offre un aggiornamento di alto livello sulle principali novità in epatologia: epatocarcinoma (con Roundtable congiunto tra esperti del BCLC di Barcellona e di Napoli), colestasi, MASLD/MASH e epatiti virali. La seconda giornata approfondisce epatiti C, B e delta, cirrosi e complicanze (insufficienza renale, ipertensione portale, encefalopatia). L'evento, accreditato con 7,7 crediti ECM per 11 ore formative, riunisce esperti nazionali e internazionali con l'obiettivo di promuovere una gestione più personalizzata e centrata sul paziente.
Provider
Lomea Soc. Coop…Lomea Soc. Cooperativa (6226)
Crediti ECM
7,7
Costo
Gratuito
Durata
11 ore
Date
9 - 10 ottobre 2026
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
"News in Hepatology" is an event dedicated to updates and discussions on the evolution of diagnostic and therapeutic pathways in hepatology. In recent years, the management of liver disease has involved an increasing number of specialists within a well-established integrated and multidisciplinary approach. Extraordinary advances have been achieved in the therapeutic field over the past decade, ranging from antiviral therapies to novel agents for the treatment of cholestasis, as well as innovations in the management of steatohepatitis. The conference will therefore provide an opportunity for specialists involved in liver disease management to discuss emerging therapeutic paradigms for MASLD, viral liver diseases, and cholestasis. The session dedicated to cirrhosis will primarily focus on renal dysfunction in advanced liver disease and on therapeutic strategies for portal hypertension. The role of the microbiota in liver failure, along with the potential effects of its modulation, will also be explored. A central section will be devoted to hepatocellular carcinoma. The Barcelona Clinic Liver Cancer (BCLC) staging system has long been considered the reference framework for the diagnosis, staging, and treatment allocation of HCC. However, in recent years, its evolution has increasingly emphasized stage migration, personalization of care, and the integration of novel therapeutic options, particularly immunotherapy. Within this context, different countries have developed specific interpretations and applications of international guidelines. Italy and Spain, both with extensive experience in HCC management and well-established transplant programs, often share common principles but may differ in clinical practice, treatment sequencing, and decision-making strategies. By fostering an open discussion among leading specialists, this session aims to highlight similarities and differences in clinical approaches, identify areas of convergence, and promote a more harmonized and patient-centered management of HCC. The conference aims to provide a high-level scientific update, with the participation of leading experts, addressing the most current and innovative topics in hepatology.
Luogo
Hotel Palazzo Alabardieri
Via Alabardieri, 38, Napoli (NA)
Programma
- 08:15Registration of participants
- 08:30Welcome address and opening remarksG.G. Di Costanzo, M. Sanduzzi Zamparelli
- 09:00BCLC at Naples Roundtable – BCLC: philosophy and daily practiceM. Reig
- 10:00BCLC at Naples Roundtable – Integrated management of systemic therapy for hepatocellular carcinomaE. Martinelli
- 10:30Coffee break
- 11:00BCLC at Naples Roundtable – Experiences from BCLCC. Ayuso, M. Campos, A. Fernandez, J. Ferrer, M. Fortuny, C. Fuster, G. Iserte, N. Llarch, J. Rimola, M. Sanduzzi Zamparelli
- 11:45BCLC at Naples Roundtable – Experiences from NaplesC. Camillo, A. Cozzolino, D. Ferraro, A. Genova, F. Giurazza, E. Guadagno, A. Santonicola, F. Verde
- 12:30BCLC at Naples Roundtable ��� Ongoing collaborative projects BCLC-NaplesM. Sanduzzi Zamparelli
- 13:00Lunch
- 14:00Cholestasis – Who and how to test for PFIC?P. Invernizzi
- 14:20Cholestasis – Second-line therapies in PBC
- 14:40Cholestasis – Biliary endoscopy 2.0: innovations and new therapeutic strategiesF.P. Zito
- 15:00Cholestasis – Daily practice and discussionA. Cavalli, P. Coccoli, V. Cossiga, F. D'Antuono, F.P. Picciotto
- 15:20MASLD – MASLD/MASH: from hepatic pathogenesis to systemic complicationsM. Masarone
- 15:40MASLD – Biomarkers of metabolic syndromeG. Svegliati Baroni
- 16:00Coffee break
- 16:30MASLD – MASLD/MASH Landscape in new therapiesR. Sacco
- 16:50MASLD – Role of Endoscopy in metabolic dysfunctionG. Galasso
- 17:10MASLD – Sarcopenia in liver cirrhosisA. Federico
- 17:30MASLD – DiscussionS. Astretto, M.R. Attanasio, G. Cordone, S. Grassi, A. Lombardi, A. Martino
Responsabili del corso
LOMEA SOC. COOPERATIVA
Provider
ID Provider: N° 6226
Città: Sant'Agata De' Goti (BN)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard
Giovan Giuseppe Di Costanzo
Responsabile scientifico
Specializzazione: Direttore Unità Operativa di Epatologia, A.O.R.N
Struttura: Napoli
Relatori e docenti
Costanza Camillo
Relatore
Struttura: Napoli
Ernesto Claar
Relatore
Struttura: Napoli
Nicola Coppola
Relatore
Struttura: Napoli
Antonio Cozzolino
Relatore
Struttura: Pozzuoli (NA)
Alessandro Federico
Relatore
Con il contributo non vincolante di
- ASTRAZENECA SPA
- GILEAD SCIENCES SRL
- GRIFOLS ITALIA SPA
- IPSEN SPA
- MADRIGAL PHARMACEUTICAL SRL
Domande frequenti
Questo evento è accreditato per: Medico Chirurgo (Gastroenterologia, Geriatria, Oncologia, Malattie Infettive, Scienza Dell'alimentazione E Dietetica, Medicina Interna, Chirurgia Generale, Radiodiagnostica).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.